Testing For COVID-19 20% Higher Among Patients With Immune-Mediated Inflammatory Disease, Study Finds

September 28, 2021

Healio (9/27, Laday) reports, “Patients with immune mediated inflammatory diseases are tested for COVID-19 at a 20% higher rate than the general population, according to” a study. Despite a higher rate of testing, however, “the risk for SARS-CoV-2 infecti...